Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA.

JAMA. 2004 Sep 15;292(11):1317-25.

PMID:
15367553
2.

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.

Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N.

Eur J Cancer. 2007 Sep;43(13):1905-17. Epub 2007 Aug 2. Review.

PMID:
17681781
3.

Screening for hereditary breast cancer.

Dent R, Warner E.

Semin Oncol. 2007 Oct;34(5):392-400. Review.

PMID:
17920893
4.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

5.

Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review.

Bermejo-Pérez MJ, Márquez-Calderón S, Llanos-Méndez A.

Br J Radiol. 2008 Mar;81(963):172-9. doi: 10.1259/bjr/21074350. Epub 2008 Jan 21. Review.

PMID:
18208856
6.

Intensified surveillance for early detection of breast cancer in high-risk patients.

Bick U.

Breast Care (Basel). 2015 Feb;10(1):13-20. doi: 10.1159/000375390. Review.

7.

Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations.

Robson M.

Clin Breast Cancer. 2004 Oct;5(4):260-8; discussion 269-71. Review.

PMID:
15507170
8.

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D.

Ann Intern Med. 2008 May 6;148(9):671-9. Review.

PMID:
18458280
9.

The problems with risk selection; scientific and psychosocial aspects.

Hartman AR.

Recent Results Cancer Res. 2005;166:125-44. Review.

PMID:
15648188
10.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
11.

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.

Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S.

Breast Cancer Res Treat. 2017 Apr;162(2):225-230. doi: 10.1007/s10549-017-4122-y. Epub 2017 Jan 30. Review.

PMID:
28138892
12.

Breast cancer: new technologies for risk assessment and diagnosis.

Wright T, McGechan A.

Mol Diagn. 2003;7(1):49-55. Review.

PMID:
14529321
13.

Benefits and Harms of Breast Cancer Screening: A Systematic Review.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD.

JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. Review. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

PMID:
26501537
14.

Breast cancers detected with imaging screening in the BRCA population: emphasis on MR imaging with histopathologic correlation.

Causer PA, Jong RA, Warner E, Hill K, Wong JW, Curpen BN, Plewes DB.

Radiographics. 2007 Oct;27 Suppl 1:S165-82. doi: 10.1148/rg.27si075503. Review.

PMID:
18180225
15.

Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2016 Jul 1;16(15):1-71. eCollection 2016. Review.

16.
17.

Screening for breast cancer.

Elmore JG, Armstrong K, Lehman CD, Fletcher SW.

JAMA. 2005 Mar 9;293(10):1245-56. Review.

18.

Clinical management of hereditary breast cancer syndromes.

Clark AS, Domchek SM.

J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):17-25. doi: 10.1007/s10911-011-9200-x. Epub 2011 Mar 1. Review.

PMID:
21360002
19.

BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers.

Levavi H, Sabah G.

Eur J Gynaecol Oncol. 2003;24(6):463-6. Review.

PMID:
14658581
20.

Recent developments in the ability to predict and modify breast cancer risk.

Prado A, Andrades P, Parada F.

J Plast Reconstr Aesthet Surg. 2010 Oct;63(10):1581-7. doi: 10.1016/j.bjps.2009.06.034. Epub 2009 Aug 8. Review.

PMID:
19666246

Supplemental Content

Support Center